EF
Therapeutic Areas
Upstream Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Verekitug (UPB-101) | Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) | Phase 2 |
Leadership Team at Upstream Bio
RS
Rand Sutherland, MD
Chief Executive Officer
AD
Aaron Deykin, MD
Chief Medical Officer & Head of R&D
MG
Mike Gray, MBA
Chief Financial Officer and Chief Operating Officer
AH
Adam Houghton, PhD
Chief Business Officer
SP
Stacy Price, MS, PMP
Chief Technology Officer
AA
Allison Ambrose
General Counsel
LF
Lisa Fiering
Senior Vice President, People & Culture
RR
Ron Renaud
Chair, Board of Directors
EC
Erez Chimovits
Partner, OrbiMed Advisors, LLC (Board Member)
LR
Liam Ratcliffe, MD, PhD
Head of Biotechnology, Access Industries (Board Member)